PMDA drug package insert
モメタゾン点鼻液50μg「タカタ」56噴霧用
PMDA Prescription drug · 高田製薬株式会社 · package insert Aug 20, 2025
Key facts
| Brand names | モメタゾン点鼻液50μg「タカタ」56噴霧用, モメタゾン点鼻液50μg「タカタ」112噴霧用 |
|---|---|
| Nonproprietary names | モメタゾンフランカルボン酸エステル水和物 |
| Companies | 製造販売元／高田製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 定量噴霧式アレルギー性鼻炎治療剤 |
| Therapeutic category codes | 871329 |
| YJ codes | 1329710Q1060, 1329710Q2066 |
| Approval numbers | 30100AMX00198, 30100AMX00199 |
| Package insert edition | 第2版 |
| Package insert date | Aug 20, 2025 |
| PMDA document key | 400186_1329710Q1060_1 |
| PMDA company code | 400186 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: